Rocket


Overview
Financials
News + Filings
IR Vault
Key Docs
Charts
Transactions
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Quarterly results
CC transcript
Appointed director
Inv. presentation
Acq. announced
ENDO HEALTH SOLUTIONS INC. (ENDP) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/28/2014 8-K Quarterly results
02/28/2014 8-K Quarterly results
Docs: "ENDO REPORTS FOURTH QUARTER AND FULL YEAR 2013 FINANCIAL RESULTS"
02/26/2014 8-K Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits
Docs: "Endo Announces Shareholder Approval of its Acquisition of Paladin Labs"
02/19/2014 8-K Material Impairments, Other Events, Financial Statements and Exhibits
Docs: "ENDO ANNOUNCES 2013 NON-CASH CHARGES"
01/21/2014 8-K Termination of a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
01/09/2014 8-K Entry into a Material Definitive Agreement, Material Impairments, Financial Statements and Exhibits
Docs: "ENDO ANNOUNCES DIVESTITURE OF HEALTHTRONICS"
12/19/2013 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Indenture, between Endo Finance Co. and Wells Fargo Bank, National Association, as trustee"
12/19/2013 8-K Other Events, Financial Statements and Exhibits
Docs: "Endo Announces Early Termination of HSR Act Waiting Period and Canadian Competition Act Compliance in Connection with Its Proposed Acquisition of Paladin Labs"
12/16/2013 8-K Acquisition/merger/asset purchase announced
12/12/2013 8-K Other Events, Financial Statements and Exhibits
Docs: "ENDO HEALTH SOLUTIONS ANNOUNCES PROPOSED PRIVATE OFFERING OF SENIOR NOTES",
"ENDO HEALTH SOLUTIONS ANNOUNCES PRICING OF PRIVATE OFFERING OF SENIOR NOTES"
12/10/2013 8-K Appointed a new director
Docs: "Arthur J. Higgins Joins Endo Board of Directors"
12/03/2013 8-K Form 8-K - Current report
11/12/2013 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
Docs: "Slide Presentation of Endo Health Solutions Inc."
09/10/2013 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Executive Employment Agreement between Endo Health Solutions Inc. and Suketu P. Upadhyay, and effective September 23, 2013",
"Endo Health Solutions Announces Appointment of Suketu Upadhyay as New Chief Financial Officer"
08/28/2013 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Endo to Acquire Specialty Generics Company Boca Pharmacal • Unique Generics Product Portfolio, Attractive Pipeline, Builds On Qualitest’s Strength In Controlled Substances • Transaction Expected To Be Immediately Accretive To Endo’s Adjusted Diluted EPS • Transaction Reflects Endo’s Ongoing Transformation of Endo Into a Leading Specialty Healthcare Company"
08/06/2013 8-K Quarterly results
Docs: "ENDO REPORTS SECOND QUARTER FINANCIAL RESULTS"
06/20/2013 8-K Entry into a Material Definitive Agreement
06/10/2013 8-K Cost Associated with Exit or Disposal Activities, Material Impairments
06/05/2013 8-K Termination of a Material Definitive Agreement, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
Docs: "Notice of Termination, effective as of July 1, 2013, of the Sales and Promotional Services Agreement by and between Ventiv Commercial Services, LLC and Endo Pharmaceuticals",
"Slide Presentation",
"ENDO HEALTH SOLUTIONS ANNOUNCES ACTIONS TO STREAMLINE OPERATIONS AND EXPAND PLATFORM FOR SUSTAINABLE CASH FLOW AND EARNINGS GROWTH"
05/07/2013 8-K Quarterly results
Docs: "ENDO REPORTS FIRST QUARTER FINANCIAL RESULTS"
03/08/2013 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Executive Employment Agreement between Endo Health Solutions Inc. and Alan G. Levin, effective as of June 1, 2013"
03/06/2013 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Slide Presentation of Endo Health Solutions Inc."
02/28/2013 8-K Quarterly results
Docs: "ENDO REPORTS FOURTH QUARTER FINANCIAL RESULTS AND REAFFIRMS 2013 FINANCIAL GUIDANCE"
02/25/2013 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Executive Employment Agreement between Endo Health Solutions Inc. and Rajiv De Silva, and effective as of March 18, 2013",
"Rajiv De Silva Named President and CEO of Endo Health Solutions Brings Extensive Leadership And Operations Experience in Healthcare Industry"
02/20/2013 8-K Other Events, Financial Statements and Exhibits
Docs: ".1"
01/07/2013 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Slide Presentation of Endo Health Solutions Inc."
01/07/2013 8-K Termination of a Material Definitive Agreement, Other Events
12/03/2012 8-K Other Events, Financial Statements and Exhibits
Docs: "ENDO HEALTH SOLUTIONS SUES FDA TO PROTECT CONSUMERS FROM NON-TAMPER RESISTANT OXYMORPHONE"
11/15/2012 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Slide Presentation of Endo Health Solutions Inc."
11/05/2012 8-K Quarterly results
Docs: "ENDO REPORTS THIRD QUARTER FINANCIAL RESULTS AND UPDATES 2012 FINANCIAL GUIDANCE"
10/23/2012 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
09/27/2012 8-K Other Events
Docs: "Endo Health Solutions Announces Receipt of Paragraph IV Certifications for OPANA ® ER Endo will vigorously defend OPANA ER intellectual property rights"
09/27/2012 8-K Entry into a Material Definitive Agreement
08/24/2012 8-K Other Events, Financial Statements and Exhibits
Docs: "STATEMENT ON FDA DECISION REGARDING ENDO CITIZEN PETITION AND APPROVAL OF A GENERIC FORMULATION OF LIDODERM ® CHADDS FORD, Pa. August 23, 2012 - Endo Health Solutions today issued the following statement regarding the U.S. Food and Drug Administration's response to Endo's Citizen Petition related to the approval requirements for generic versions of LIDODERM , a locally-acting topical medication for the relief of pain associated with post-herpetic neuralgia. “We are disappointed in FDA's decision to deny the citizen petition and approve a generic version of LIDODERM. The company believes that the approval of a generic version of LIDODERM without requiring clinical endpoint studies is inadequate to establish the safety and efficacy of this locally-acting topical medication. The company antic..."
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy